NDTDI

From Wikipedia, the free encyclopedia
NDTDI
NDTDI structure.png
Legal status
Legal status
  • Illegal in Latvia
Identifiers
  • N,N-diethyl-3-(methyl(1,3,4,5-tetrahydrobenzo[cd]indol-4-yl)amino)propanamide
Chemical and physical data
FormulaC19H27N3O
Molar mass313.445 g·mol−1
3D model (JSmol)
  • CCN(CC)C(=O)CCN(C)C1Cc3cccc2ncc(C1)c23

NDTDI is a tricyclic tryptamine derivative which is thought to act as a serotonin receptor agonist, though its pharmacology has not been studied in detail. It is a structurally simplified analogue of LSD and is reported to retain similar effects, though with many times lower potency. It has been sold as a designer drug since 2016 and was first identified by a forensic laboratory in Slovenia in 2017.[1]

Legality[edit]

NDTDI was made illegal in Latvia in March 2017.[2]

See also[edit]

References[edit]